NexPoint Capital, Inc. Concludes Recent Tender Offer for Common Stock

NexPoint Capital's Tender Offer Overview

NexPoint Capital, Inc., a business development entity managed by NexPoint Advisors, recently completed its tender offer for its common stock. As outlined in their announcement dated December 19, 2025, the offer targeted up to 1.5% of its outstanding shares at a redemption price of $4.75 per share.

Key Details of the Tender Offer

The company's tender offer officially concluded on December 16, 2025, at 4 p.m. Eastern Time. During this period, a total of 127,320.8299 shares were tendered for repurchase by NexPoint. The completion of this tender offer reflects NexPoint's ongoing commitment to managing shareholder returns in a competitive financial landscape.

Implications for Shareholders

Shareholders interested in the results of this offer can obtain more detailed information through NexPoint's official investor relations portal at nexpoint.com. This exercise provides a unique opportunity for shareholders to realize value from their investments, especially in light of potential market fluctuations.

About NexPoint Capital

NexPoint Capital, Inc. is not just another investment firm; it operates as a non-traded, publicly registered business development corporation. With a focus on a robust healthcare investment strategy, NexPoint's mission is to create long-term value for its investors.

The entity is part of the NexPoint Advisors, L.P. family, which is an SEC-registered adviser that provides management services for a variety of investment products, including closed-end funds and interval funds.

Forward-Looking Statements and Considerations

It’s important to note that the content of this announcement includes forward-looking statements that might involve risks and uncertainties. Such uncertainties could impact the actual results that NexPoint Capital, Inc. achieves, including changes in economic conditions and performance in financial markets.

Contact Information

For any inquiries related to the tender offer, shareholders and financial advisers are encouraged to reach out to NexPoint's designated tender agent, LODAS Transfer, LLC, at (833) 586-1960. Moreover, media representatives can contact the company through their press representative via their dedicated media email.

Conclusion

In closing, the completion of this tender offer marks another strategic move for NexPoint Capital, providing an avenue for returns for its shareholders. The firm continuously evaluates its strategies and offerings to align with the best interests of its investors amidst the evolving economic landscape. With a keen focus on healthcare investments, NexPoint is poised to explore further opportunities while adjusting to market dynamics.